Drawing for CERULEAN

USPTO serial 85442528

CERULEAN

Reviewed by CopyMark Law Group

Reg. 4659912Status 710
Filing date
Status date
Registration date
Dec 23, 2014
Examiner
DELANEY, ZHALEH SYBIL
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CERULEAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David Ehrlich

DAVID EHRLICH FROSS ZELNICK LEHRMAN & ZISSU, P.C.4 TIMES SQUARE, 17TH FLOORNEW YORK, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for use in the diagnosis, prognosis or prevention of oncological diseases or disorders, including malignant cancers or neoplasms; pharmaceutical preparations for use in the diagnosis, prognosis, prevention or treatment of oncological diseases or disorders, including pre-cancerous diseases or disorders and benign cancers or neoplasms; pharmaceutical preparations for use in modulating angiogenesis; pharmaceutical preparations for use in the diagnosis, prognosis and prevention of oncological diseases or disorders, including malignant cancers or neoplasms, all containing nanometer size compounds which facilitate targeting or delivery of the active ingredient; pharmaceutical preparations for use in the diagnosis, prognosis, prevention or treatment of oncological diseases or disorders, including pre-cancerous diseases or disorders and benign cancers or neoplasms, all containing nanometer size compounds which facilitate targeting or delivery of the active ingredient; pharmaceutical preparations for use in modulating angiogenesis, containing nanometer size compounds which facilitate targeting or delivery of the active ingredientSECTION 8 - CANCELLEDMay 21, 2012

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 30, 2021C8..CANCELLED SEC. 8 (6-YR)—
Dec 23, 2019REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 5, 2017CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED—
Jan 31, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 11, 2016CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 11, 2016COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 23, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 19, 2014SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED—
Nov 18, 2014CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Nov 18, 2014SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 12, 2014IUAFUSE AMENDMENT FILED—
Nov 12, 2014EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 20, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
May 19, 2014EX4GSOU EXTENSION 4 GRANTED—
May 12, 2014EXT4SOU EXTENSION 4 FILED—
May 12, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 31, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Oct 30, 2013EX3GSOU EXTENSION 3 GRANTED—
Oct 16, 2013EXT3SOU EXTENSION 3 FILED—
Oct 16, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 4, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Jun 3, 2013EX2GSOU EXTENSION 2 GRANTED—
May 7, 2013EXT2SOU EXTENSION 2 FILED—
May 7, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 10, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Aug 10, 2012NOACCORRECTED NOA MAILED—
Aug 9, 2012EX1GSOU EXTENSION 1 GRANTED—
Aug 9, 2012DPCCDIVISIONAL PROCESSING COMPLETE—
Aug 7, 2012AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 24, 2012EXT1SOU EXTENSION 1 FILED—
Jul 24, 2012DRRRDIVISIONAL REQUEST RECEIVED—
Jul 24, 2012ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Jul 24, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 15, 2012NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 20, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 29, 2012NPUBNOTICE OF PUBLICATION—
Jan 31, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 25, 2012DOCKASSIGNED TO EXAMINER—
Oct 14, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 11, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance